An Overview of Recent Advances in Mineral Metabolism

  • Saulo Klahr
  • Eduardo Slatopolsky
  • Kevin Martin


The last decade witnessed a dramatic expansion of knowledge, both fundamental and clinical, about the metabolism of calcium and phosphorus, and about the regulation of bone structure and function in health and disease. Calcium and phosphorus are essential components of the skeleton, which regulate or modulate many biochemical and transport processes. Cystosolic and extracellular fluid concentrations of ionic calcium are maintained within narrow limits despite wide fluctuation in calcium intake. The circulating levels of phosphorus are controlled by many of the same factors responsible for regulating calcium metabolism, though to a less stringent degree.


Parathyroid Hormone Parathyroid Gland Mineral Metabolism Metabolic Bone Disease Chronic Renal Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Rasmussen H, Bordier, P: The Physiological and Cellular Basis of Metabolic Bone Disease. Baltimore, Williams & Wilkins, 1974.Google Scholar
  2. 2.
    Avioli LV, Krane SM (eds): Metabolic Bone Disease, Volumes I and II. New York, Academic Press, 1977, 1978.Google Scholar
  3. 3.
    Parfitt AM: The actions of parathyroid hormone on bone: Relation to bone remodeling and turnover, calcium homeostasis, and metabolic bone diseases. I. Mechanisms of calcium transfer between blood and bone and their cellular basis: Morphological and kinetic approaches to bone turnover. Metabolism 25:809–844, 1976.PubMedCrossRefGoogle Scholar
  4. 4.
    Parfitt AM: The actions of parathyroid hormone on bone: Relation to bone remodeling and turnover, calcium homeostasis, and metabolic bone diseases. II. PTH and bone cells; bone turnover and plasma calcium regulation. Metabolism 25:909–955, 1976.PubMedCrossRefGoogle Scholar
  5. 5.
    Parfitt AM: The actions of parathyroid hormone on bone: Relation to bone remodeling and turnover, calcium homeostasis, and metabolic bone diseases. III. PTH and osteoblasts, the relationship between bone turnover and bone loss, and the state of bones in primary hyperparathyroidism. Metabolism 25:1033–1069, 1976.PubMedCrossRefGoogle Scholar
  6. 6.
    Parfitt AM: The actions of parathyroid hormone on bone: Relation to bone remodeling and turnover, calcium homeostasis, and metabolic bone diseases. IV. The state of bones in uremic hyperparathyroidism—the mechanisms of skeletal resistance to PTH in renal failure and pseudohypoparathyroidism and the role of PTH in osteoporosis, osteopetrosis and osteofluorosis. Metabolism 25:1157–1188, 1976.PubMedCrossRefGoogle Scholar
  7. 7.
    DeLuca HF, Schnoes HK: Metabolism and mechanism of action of vitamin D. Annu Rev Biochem 45:631–666, 1976.PubMedCrossRefGoogle Scholar
  8. 8.
    Hausier MR, McCain TA: Basic and clinical concepts related to vitamin D metabolism and action. N Engl J Med 297:974–983, 1977.CrossRefGoogle Scholar
  9. 9.
    Habener JF, Potts JT; Parathyroid physiology and primary hyperparathyroidism, in Avioli LV, Krane SM (eds): Metabolic Bone Disease, Volume II. New York, Academic Press, 1978, pp. 1–147.Google Scholar
  10. 10.
    Kukreja SC, Hargis GK, Bowser EN, Henderson WJ, Fisherman EW, Williams GA: Role of adrenergic stimuli in parathyroid hormone secretion in man. J Clin Endocrinol Metab 40:478–478, 1975.PubMedCrossRefGoogle Scholar
  11. 11.
    Brown EM, Hurwitz S, Aurbach DG: Beta-adrenergic stimulation of cyclic AMP content and parathyroid hormone release from isolated bovine parathyroid cells. Endocrinology 100:1696–1702, 1977.PubMedCrossRefGoogle Scholar
  12. 12.
    Peck WA, Klahr S: Cyclic nucleotides in bone and mineral metabolism, in Greengard P, Robison GA (eds): Advances in Cyclic Nucleotide Research, Volume 11. New York, Raven Press, 1979, pp. 89–130.Google Scholar
  13. 13.
    Brown EM, Carroll RJ, Aurbach GD: Dopaminergic stimulation of cyclic AMP accumulation and parathyroid hormone release from dispersed bovine parathyroid cells. Proc Natl Acad Sci USA 74:4210–4213, 1977.PubMedCrossRefGoogle Scholar
  14. 14.
    Gardner DE, Brown EM, Windeck K, Aurbach GD: Prostaglandin E2 stimulation of adenosine 3′,5′-monophosphate accumulation and parathyroid hormone release in dispersed bovine parathyroid cells. Endocrinology 103:577–582, 1978.PubMedCrossRefGoogle Scholar
  15. 15.
    Brown EM, Gardner DG, Windeck RA, Aurbach GD: Cholera toxin stimulates 3′,5′-adenosine monophosphate accumulation and parathyroid hormone release from dispersed bovine parathyroid cells. Endocrinology 104:218–225, 1979.PubMedCrossRefGoogle Scholar
  16. 16.
    Caro JF, Burke JF, Besarab A, Glennon JA: A possible role for propranolol in the treatment of renal osteodystrophy. Lancet 2:451, 1978.PubMedCrossRefGoogle Scholar
  17. 17.
    Golden P, Mazey R, Greenwalt A, Martin K, Slatopolsky E: Vitamin D: A direct effect on the parathyroid gland? J Min Electr Metabol 2:1–6, 1979 (editorial).Google Scholar
  18. 18.
    Canterbury JM, Lerman S, Claflin AJ, Henry H, Normal A, Reiss E: Inhibition of parathyroid hormone secretion by 1,25-dihydroxycholecalciferol and 24,25-dihydroxycho-lecalciferol in the dog. J Clin Invest 61:1375–1383, 1978.PubMedCrossRefGoogle Scholar
  19. 19.
    Canterbury JM, Gavellas G, Bourgoignie JJ, Reiss E: Metabolic consequences of oral administration of 24,25(OH)2D3 to uremic dogs. J Clin Invest 65:571–576, 1980.PubMedCrossRefGoogle Scholar
  20. 20.
    Bellorin-Font E, Martin K, Freitag J, Anderson C, Sicard G, Slatopolsky E, Klahr S: Altered adenylate cyclase kinetics in hyperfunctioning parathyroid glands. J Endocrinol Clin Metab 52:499–507, 1981.CrossRefGoogle Scholar
  21. 21.
    Martin KJ, Hruska KA, Freitag JJ, Klahr S, Slatopolsky D: The peripheral metabolism of parathyroid hormone. N Engl J Med 301:1092–1098, 1979.PubMedCrossRefGoogle Scholar
  22. 22.
    Slatopolsky E, Martin K, Hruska K: Parathyroid hormone metabolism and its potential as a uremic toxin. Am J Physiol 239239:F1-F12, 1980.Google Scholar
  23. 23.
    Canterbury JM, Bricker LA, Levey JS, Kozlovskis PL, Ruiz E, Zull JE, Reiss E: Metabolism of bovine parathyroid hormone: Immunological and biological characteristics of fragments generated by liver perfusion. J Clin Invest 55:1245–1253, 1975.PubMedCrossRefGoogle Scholar
  24. 24.
    Hruska KA, Martin K, Mennes P, Greenwalt S, Anderson C, Klahr S, Slatopolsky S: Degradation of parathyroid hormone and fragment production by the isolated perfused dog kidney. The effect of glomerular filtration rate and perfusate Ca++ concentrations. J Clin Invest 60:501–510, 1977.PubMedCrossRefGoogle Scholar
  25. 25.
    Bourgoignie JJ, Jacob AI, Lanier D Jr, Gavellas G, Canterbury J: Cimetidine (C) inhibition of iPTH in chronic renal disease. Abstracts American Society of Nephrology 12th Annual Meeting, Kidney Int 16:918, 1979.Google Scholar
  26. 26.
    Cunningham J, Segre GV, Slatopolsky E, Avioli LV: Effect of histamine H2-receptor blockade on parathyroid status in normal and uremic man (editorial). Am J Nephrol 4:205–207, 1984.PubMedCrossRefGoogle Scholar
  27. 27.
    Mennes P, Rosenbaum R, Martin K, Slatopolsky E: Hypomagnesemia and impaired parathyroid hormone secretion in chronic renal disease. Ann Int Med 8888:206, 1978.Google Scholar
  28. 28.
    Massry S, Coburn JW, Kleeman CR: Evidence for suppression of parathyroid gland activity by hypermagnesemia. J Clin Invest 49:1619–1629, 1970.PubMedCrossRefGoogle Scholar
  29. 29.
    Slatopolsky E, Gray R, Adams ND, Lewis J, Hruska K, Martin K, Klahr S, DeLuca H, Lemann J: The pathogenesis of secondary hyperparathyroidism in early renal failure. Fourth International Workshop on Vitamin D, Berlin, 1979.Google Scholar
  30. 30.
    Malluche HH, Goldstein DA, Massry SG: Osteomalacia and hyperparathyroid bone disease in patients with nephrotic syndrome. J Clin Invest 63:494–500, 1979.PubMedCrossRefGoogle Scholar
  31. 31.
    Price PA, Poser JW, Raman N: Primary structure of the γ-carboxyglutamic acid-containing protein from bovine bone. Proc Natl Acad Sci USA 73:3374–3375, 1976.PubMedCrossRefGoogle Scholar
  32. 32.
    Nishimoto SK, Price PA: Proof that the γ-carboxyglutamic acid-containing bone protein is synthesized in calf bone. J Biol Chem 254:437–441, 1979.PubMedGoogle Scholar
  33. 33.
    Price PA, Nishimoto S, Parthemore JG, Deftos LJ: A new biochemical marker for bone metabolism. Proceedings of the First Annual Meeting of the American Society for Bone and Mineral Research, Abstract #14A, 1979.Google Scholar
  34. 34.
    Price PA, Epstein DJ, Lothringer JW, Nishimoto SK, Poser JW, Williamson MK: Structure and function of the vitamin K-dependent protein of bone, in Suttie JW (ed): Vitamin K Metabolism and Vitamin K-Dependent Proteins. Baltimore, University Park Press, 1979, pp. 219–226.Google Scholar

Copyright information

© Plenum Publishing Corporation 1985

Authors and Affiliations

  • Saulo Klahr
    • 1
  • Eduardo Slatopolsky
    • 1
  • Kevin Martin
    • 1
  1. 1.Renal Division, Department of MedicineWashington University School of MedicineSt. LouisUSA

Personalised recommendations